These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12161379)

  • 1. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?
    Pérez-Encinas M; Rabuñal Martínez MJ; Bello López JL
    Haematologica; 2002 Aug; 87(8):ELT34. PubMed ID: 12161379
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY; Chen Y; Du Q
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
    Bowcock SJ; Patrick HE
    Br J Haematol; 2009 Jul; 146(2):220-2. PubMed ID: 19438503
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of desmopressin on massive gastrointestinal bleeding in hereditary telangiectasia unresponsive to treatment with cryoprecipitate.
    Quitt M; Froom P; Veisler A; Falber V; Sova J; Aghai E
    Arch Intern Med; 1990 Aug; 150(8):1744-6. PubMed ID: 2116786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Proctor DD; Henderson KJ; Dziura JD; White RI
    J Clin Gastroenterol; 2008 Jul; 42(6):756-7. PubMed ID: 18496387
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiogenesis inhibitors for treatment of angiodysplasia-related gastrointestinal bleeding].
    Bauditz J
    Dtsch Med Wochenschr; 2009 Sep; 134(38):1893-6. PubMed ID: 19746332
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Pitini V; Arrigo C; Aloi G; Micali C; La Gattuta G
    Bone Marrow Transplant; 2003 Jun; 31(11):1065; author reply 1067. PubMed ID: 12774062
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Nunzi M; Grasso M; Falco P; Cangialosi C; Boccadoro M
    Cancer; 2005 Oct; 104(7):1428-33. PubMed ID: 16116606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal manifestations of hereditary haemorrhagic teleangiectasia.
    Kristoffersson A; Domellöf L; Kullenberg K
    Ann Chir Gynaecol; 1987; 76(2):96-8. PubMed ID: 3497606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on thalidomide usage in myeloma.
    Myers B
    Haematologica; 2002 Jun; 87(6):ELT29. PubMed ID: 12031937
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA; Sami S; Babu S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric radiotherapy as treatment of hereditary hemorrhagic telangiectasia.
    Schwartz JT; Patton GA; Graham DY; Cain GD
    Am J Gastroenterol; 1982 Jan; 77(1):53-4. PubMed ID: 6978066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic angiodysplasia of the digestive tract: pathogenesis, diagnosis, and management.
    Becq A; Rahmi G; Perrod G; Cellier C
    Gastrointest Endosc; 2017 Nov; 86(5):792-806. PubMed ID: 28554655
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide in multiple myeloma.
    Thomas SK; Richards TA; Weber DM
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemorrhagic telangiectasias as a rare cause of recurrent gastrointestinal bleeding.
    Januszewicz W; Jóźwik-Plebanek K; Wrońska E; Kabat M; Januszewicz A; Reguła J
    Pol Arch Med Wewn; 2016 May; 126(5):363-4. PubMed ID: 27230665
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontline treatment of multiple myeloma in elderly patients.
    Moreau P; Hulin C; Facon T
    Blood Rev; 2008 Nov; 22(6):303-9. PubMed ID: 18550234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.